ENTA vs UAL · rev $65.3M vs P/E 10, rev $32.28B
Enanta Pharmaceuticals Inc (ENTA) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Latest reported UAL revenue for 2026-06-30 was $32.28B. Net income was $1.50B. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
ENTA currently screens at market cap $328.0M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the ENTA and UAL stock pages for the full models.
Not investment advice.